BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24048800)

  • 1. Variation in quality of care among older men with localized prostate cancer.
    Jayadevappa R; Chhatre S; Johnson JC; Malkowicz SB
    Cancer; 2011 Jun; 117(11):2520-9. PubMed ID: 24048800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE).
    Chhatre S; Bruce Malkowicz S; Sanford Schwartz J; Jayadevappa R
    Medicine (Baltimore); 2015 Aug; 94(32):e1353. PubMed ID: 26266389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in urologist visits among elderly men with prostate cancer: a cohort analysis of patient-related and county of residence-related factors.
    Onukwugha E; Osteen P; Jayasekera J; Mullins CD; Mair CA; Hussain A
    Cancer; 2014 Nov; 120(21):3385-92. PubMed ID: 24962590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
    Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
    Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment.
    Slezak JM; Van Den Eeden SK; Cannavale KL; Chien GW; Jacobsen SJ; Chao CR
    Cancer Med; 2020 Nov; 9(22):8530-8539. PubMed ID: 32965775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial variation in receipt of quality radiation therapy for prostate cancer.
    Lee DJ; Zhao Z; Huang LC; Koyoma T; Resnick MJ; Penson DF; Barocas DA; Hoffman KE
    Cancer Causes Control; 2018 Oct; 29(10):895-899. PubMed ID: 30099628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation.
    Feldman AS; Meyer CP; Sanchez A; Krasnova A; Reznor G; Menon M; Kibel AS; Choueiri TK; Lipsitz SR; Sun M; Trinh QD
    J Urol; 2017 Nov; 198(5):1061-1068. PubMed ID: 28552709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
    Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
    Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuity of care and advanced prostate cancer.
    Jayadevappa R; Guzzo T; Vapiwala N; Malkowicz SB; Gallo JJ; Chhatre S
    Cancer Med; 2023 May; 12(10):11795-11805. PubMed ID: 36951508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.
    Washington SL; Jeong CW; Lonergan PE; Herlemann A; Gomez SL; Carroll PR; Cooperberg MR
    JAMA Netw Open; 2020 Dec; 3(12):e2031349. PubMed ID: 33369661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic variation in health resource use and cost for prostate cancer.
    Jayadevappa R; Malkowicz SB; Chhatre S; Gallo J; Schwartz JS
    BJU Int; 2010 Sep; 106(6):801-8. PubMed ID: 20151963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between hospital competition and quality of prostate cancer care.
    Jayadevappa R; Malkowicz SB; Vapiwala N; Guzzo TJ; Chhatre S
    BMC Health Serv Res; 2023 Aug; 23(1):828. PubMed ID: 37543580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N; Dong W; Koroukian SM
    Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men.
    Klebaner D; Courtney PT; Garraway IP; Einck J; Kumar A; Martinez ME; McKay R; Murphy JD; Parada H; Sandhu A; Stewart T; Yamoah K; Rose BS
    J Natl Cancer Inst; 2021 Oct; 113(10):1343-1351. PubMed ID: 33892497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study.
    Katz JE; Chinea FM; Patel VN; Balise RR; Venkatramani V; Gonzalgo ML; Ritch C; Pollack A; Parekh DJ; Punnen S
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):533-538. PubMed ID: 29988097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years.
    Huang H; Muscatelli S; Naslund M; Badiyan SN; Kaiser A; Siddiqui MM
    J Urol; 2019 Jan; 201(1):120-128. PubMed ID: 30059685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial/ethnic disparities in the treatment of localized/regional prostate cancer.
    Underwood W; De Monner S; Ubel P; Fagerlin A; Sanda MG; Wei JT
    J Urol; 2004 Apr; 171(4):1504-7. PubMed ID: 15017208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.